BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
2.180
+0.020 (0.93%)
At close: Jul 8, 2026, 4:00 PM EDT
2.170
-0.010 (-0.46%)
After-hours: Jul 8, 2026, 6:27 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $16.44 million as of July 8, 2026. Its market cap has decreased by -12.08% in one year.
Market Cap
16.44M
Enterprise Value
3.64M
1-Year Change
-12.08%
Ranking
Category
Stock Price
$2.18
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $16.44M, a decrease of -68.38%. That is a compound annual growth rate of -17.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 16.44M | 88.98% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 17.98M |
| Pasithea Therapeutics | 17.37M |
| Quince Therapeutics | 17.11M |
| Werewolf Therapeutics | 16.72M |
| GT Biopharma | 16.59M |
| Passage Bio | 16.04M |
| Citius Pharmaceuticals | 16.02M |
| Moolec Science | 16.00M |